Aytu BioScience (NASDAQ: AYTU) is a growing specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company markets Natesto (testosterone nasal gel, C III), ZolpiMist (zolpidem tartrate oral spray, CIV), and Tuzistra XR (codeine polistirex & chlorpheniramine polistirex, CIII) in the United States and plans to in-license or acquire…More additional novel products to complement the company's therapeutic portfolio.